FeesSafety
Pluang+

Ethereum advances leanVM project for post-quantum security but tool not production-ready yet

Protocol Fundamentals
04 Nov 2026, 08:32 WIB
Tokenpost
View Source
Neutral
Ethereum advances leanVM project for post-quantum security but tool not production-ready yet

Ethereum's leanVM project is developing a minimal, hash-based zkVM to aggregate leanXMSS signatures, a post-quantum alternative for validator signatures. This effort addresses the challenge that post-quantum signatures are larger and lack native aggregation like BLS signatures. The project is part of Ethereum's L* consensus and data milestone, aiming for full post-quantum protection across consensus, transactions, and data sampling in the long term. The Ethereum Foundation notes the roadmap is evolving with research and governance, highlighting the importance of quantum safety and formal verification for future upgrades.

Ethereum's leanVM project is the subject, with Pluang's market snapshot as of Nov 04, 2026 13:21 WIB showing that among 50 major cryptocurrencies, 40 rose and 9 fell today. Notably, SXP dropped sharply by 46.27% to Rp37 with a typical hold time of 94 days, contrasting with BAL which gained 11.14% to Rp16,297 and EOS which rose 8.13% to Rp12,649, both held around 85-87 days on Pluang.

More News

STMicroelectronics launches unified STM32 MCU platform for industrial, automotive, and AI applications.

STMicroelectronics launches unified STM32 MCU platform for industrial, automotive, and AI applications.

STMicroelectronics announced a unified STM32 microcontroller platform that spans industrial, automotive, and robotics applications, enabling developers to reuse architectures, software, and tools across these sectors. The new STM32A family extends th...

Market News
Bullish
1 hour ago
dsm-firmenich reports 5% sales growth and margin expansion in Q3 2026, raising full-year sales outlook to 5%.

dsm-firmenich reports 5% sales growth and margin expansion in Q3 2026, raising full-year sales outlook to 5%.

dsm-firmenich announced a strong Q3 2026 trading update with 5% like-for-like sales growth and an improved Adjusted EBITDA margin of 20.4%. The company’s performance was driven by volume growth across its three business units: Perfumery & Beauty, Tas...

Company Fundamentals
Bullish
1 hour ago
Solvay reports Q3 2026 sales down 3.3% amid Middle East conflict, advances rare earths strategy with Viridis deal.

Solvay reports Q3 2026 sales down 3.3% amid Middle East conflict, advances rare earths strategy with Viridis deal.

Solvay's Q3 2026 underlying net sales fell 3.3% organically to €1,031 million, impacted by the Middle East conflict and weak soda ash markets. EBITDA dropped 26.6% organically to €173 million, partly due to a €25 million impact from the conflict and ...

Company Fundamentals
Bearish
1 hour ago
UniCredit set for major growth with Commerzbank acquisition and strong 2024 profit outlook

UniCredit set for major growth with Commerzbank acquisition and strong 2024 profit outlook

UniCredit is expanding significantly through its planned acquisition of Commerzbank, having secured ECB approval and expecting to gain a controlling stake this year. The bank posted record second-quarter and half-year results, with a 5% increase in c...

Market News
Bullish
5 hours ago
Milestone Pharmaceuticals grants 33,000 stock options to new employee under Nasdaq inducement rule.

Milestone Pharmaceuticals grants 33,000 stock options to new employee under Nasdaq inducement rule.

Milestone Pharmaceuticals announced the grant of 33,000 stock options to a newly hired employee as an inducement under Nasdaq Listing Rule 5635(c)(4). The options, priced at $0.72 each, will vest over four years with a one-year cliff and monthly inst...

Company Fundamentals
Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App